The following is a summary of “Quality priorities related to the management of type 2 diabetes in primary care: results from the COMPAS + quality improvement collaborative,” published in the November ...

Small, gradual lifestyle changes like increasing aerobic exercise, losing weight and eating a healthy diet can reduce your ...

Early detection, insulin therapy, a balanced diet, exercise, and regular veterinary visits can help your pet live a healthy, ...

Manoj Chowdary Vattikuti, Sr. DevOps Engineer and Research Scientist at Cardinal Health, along with Niharikareddy Meenigea, ...

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Living with diabetes requires proactive lifestyle management. A balanced diet, regular exercise, and avoiding alcohol and ...

Fetch faculty members offer unique insights about behavior associated with diabetes, diabetic ketoacidosis, and new drug ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associ ...